Comparison of patients with ≤2 AFI+ areas with those with ≥3 AFI+ areas did not reveal significant differences for biomarker positivity rate for neither p53 (28% vs 33%; p = 0.6111) nor aneuploidy (11% vs 14%; p = 0.7136). The gene discussed is TP53; the disease is aneuploidy.